Today is shaping up negative for Zymeworks Inc. (NASDAQ:ZYME) shareholders, with the analysts delivering a substantial negative revision to next year's forecasts. Both revenue and earnings per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback